サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1701356

In-vitro大腸がんスクリーニング検査の市場規模、シェア、動向分析レポート：検査別、最終用途別、地域別、

In-vitro Colorectal Cancer Screening Tests Market Size, Share & Trends Analysis Report By Test (Fecal Occult Blood Tests, Biomarker Tests), By End-use (Hospitals & Clinics, Diagnostic Laboratories),By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 129 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
In-vitro大腸がんスクリーニング検査の市場規模、シェア、動向分析レポート：検査別、最終用途別、地域別、
出版日: 2025年03月21日
発行: Grand View Research
ページ情報: 英文 129 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

In-vitro大腸がんスクリーニング検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の体外結腸直腸がんスクリーニング検査市場規模は、2025年から2030年にかけてCAGR 4.7%を記録し、2030年までに17億米ドルに達する見込みです。

結腸や直腸の悪性腫瘍患者の増加に対抗するための新しいスクリーニングモデルの増加が、市場成長に影響を与える主な要因です。腫瘍M2-PK便検査やメチル化遺伝子検査など、新たに開発された遺伝子検査やバイオマーカー検査の出現は、腫瘍診断モデルの採用率を押し上げると予測されています。

大腸悪性腫瘍の罹患率の増加は、このセグメントの成長の重要なドライバーです。例えば、国立がん研究センターが2022年6月に発表したデータによると、日本では2022年に約1,019,000人の新規がん症例が発生すると予測されており、大腸がん（CRC）は推定158,200人の新規症例を占めています。同様に、Cancer Australiaが2022年8月に更新したデータによると、オーストラリアでは2022年に15,713例の新規CRC症例が診断され、男性では8,300例、女性では7,413例が診断されると予測されています。その結果、大腸悪性腫瘍の有病率の増加が大腸内視鏡検査機器の需要を牽引すると予想されます。

検診を促進するための公的機関によるさまざまなイニシアチブの実施は、体外CRC検診の需要にプラスの影響を与えています。例えば、Cancer.orgの報告によると、カリフォルニア州の医療システムは2020年4月と5月の間、FITキット（糞便免疫化学検査）の提供を継続し、COVID-19の大流行が始まったにもかかわらず、FITの反応率は高いままでした。さらに、欧州のがんコミュニティは、COVID-19が検診に及ぼす悪影響を評価し、対処し、緩和するためにリソースを動員しました。こうした努力は、体外スクリーニング検査に対する持続的な需要に寄与しています。

さらに、市場の成長は、主要な市場参入企業による製品上市の増加によって牽引されると予想されます。これらの製品発売は、技術的に高度で革新的な製品へのアクセスを提供することを目的としています。例えば、Pillar Biosciences, Inc.は、2021年7月にCRC検出用のONCO/Reveal Dx Lung &Colon Cancer Assay（O/RDx-LCCA）のFDA承認を取得しました。

In-vitro大腸がんスクリーニング検査市場レポートハイライト：

  • 便潜血検査部門がIn-vitro大腸がんスクリーニング検査業界を支配し、2024年の最大収益シェアは82.3%でした。バイオマーカー検査分野が最も急成長する分野として浮上し、2025年から2030年にかけてCAGR 5.8%で成長すると予測されます。
  • 診断研究所セグメントは2024年に最大の収益シェアを占めたが、これは高度な技術、高い精度、包括的な検査能力に起因しています。病院・診療所セグメントは、早期診断と非侵襲的検査オプションの需要増に後押しされ、予測期間中に大きなペースで成長する見込みです。
  • 北米のIn-vitro大腸がんスクリーニング検査市場は、2024年に39.5%の最大収益シェアで世界市場を独占しました。米国のIn-vitro大腸がんスクリーニング検査市場が2024年に最大のシェアを占めました。
  • アジア太平洋のIn-vitro大腸がんスクリーニング検査市場は、2025年から2030年にかけて最も速いCAGR 5.2％で拡大します。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 In-vitro大腸がんスクリーニング検査市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析

第4章 In-vitro大腸がんスクリーニング検査市場：検査別ビジネス分析

  • 検査市場シェア、2024年と2030年
  • 検査セグメントダッシュボード
  • 市場規模と予測および動向分析（検査別、2018～2030年）
  • 便潜血検査
  • バイオマーカー検査
  • その他の方法

第5章 In-vitro大腸がんスクリーニング検査市場：最終用途別ビジネス分析

  • 最終用途市場シェア、2024年および2030年
  • 最終用途セグメントダッシュボード
  • 市場規模、予測、動向分析、用途別、2018～2030年
  • 病院と診療所
  • 診断検査室
  • その他

第6章 In-vitro大腸がんスクリーニング検査市場：地域別推定・動向分析

  • 地域別市場シェア分析、2024年および2030年
  • 地域市場ダッシュボード
  • 市場規模、予測動向分析、2018年から2030年まで：
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東およびアフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/リスト
    • Abbott
    • Epigenomics AG
    • Beckman Coulter, Inc.
    • Eiken Chemical Co., Ltd.
    • Sysmex Corporation
    • Siemens Healthineers AG
    • Quest Diagnostics Incorporated
    • Oncocyte Corporation
    • Merck KGaA
    • Immunostics Inc.
    • Kyowa Kirin Co., Ltd.
    • Randox Laboratories Ltd.
    • R-Biopharm AG
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global In-vitro Colorectal Cancer Screening Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 4. Global In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 5. Global In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 6. North America In-vitro Colorectal Cancer Screening Tests Market, By Country, 2018 - 2030 (USD Million)
  • Table 7. North America In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 8. North America In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 9. U.S. In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 10. U.S. In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11. Canada In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 12. Canada In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13. Mexico In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 14. Mexico In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15. Europe In-vitro Colorectal Cancer Screening Tests Market, By Country, 2018 - 2030 (USD Million)
  • Table 16. Europe In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 17. Europe In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18. U.K. In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 19. U.K. In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20. Germany In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 21. Germany In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22. Spain In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 23. Spain In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24. France In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 25. France In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26. Italy In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 27. Italy In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28. Denmark In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 29. Denmark In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30. Sweden In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 31. Sweden In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32. Norway In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 33. Norway In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market, By Country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37. Japan In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 38. Japan In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 39. China In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 40. China In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41. India In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 42. India In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43. South Korea In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 44. South Korea In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 45. Australia In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 46. Australia In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47. Thailand In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 48. Thailand In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 49. Latin America In-vitro Colorectal Cancer Screening Tests Market, By Country, 2018 - 2030 (USD Million)
  • Table 50. Latin America In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 51. Latin America In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52. Brazil In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 53. Brazil In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54. Argentina In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 55. Argentina In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market, By Country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59. South Africa In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 60. South Africa In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63. UAE In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 64. UAE In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait In-vitro Colorectal Cancer Screening Tests Market, By Test, 2018 - 2030 (USD Million)
  • Table 66. Kuwait In-vitro Colorectal Cancer Screening Tests Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 In-vitro Colorectal Cancer Screening Tests Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Test and End Use Outlook (USD Million)
  • Fig. 11 Competitive Landscape
  • Fig. 12 In-vitro Colorectal Cancer Screening Tests Market Dynamics
  • Fig. 13 In-vitro Colorectal Cancer Screening Tests Market: Porter's Five Forces analysis
  • Fig. 14 In-vitro Colorectal Cancer Screening Tests Market: PESTLE Analysis
  • Fig. 15 In-vitro Colorectal Cancer Screening Tests Market: Test Segment Dashboard
  • Fig. 16 In-vitro Colorectal Cancer Screening Tests Market: Test Market Share Analysis, 2024 & 2030
  • Fig. 17 Fecal Occult Blood Tests Market, 2018 - 2030 (USD Million)
  • Fig. 18 Biomarker Tests Market, 2018 - 2030 (USD Million)
  • Fig. 19 Other Methods Market, 2018 - 2030 (USD Million)
  • Fig. 20 In-vitro Colorectal Cancer Screening Tests Market: End Use Segment Dashboard
  • Fig. 21 In-vitro Colorectal Cancer Screening Tests Market: End Use Market Share Analysis, 2024 & 2030
  • Fig. 22 Hospitals and Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 23 Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
  • Fig. 24 Others Market, 2018 - 2030 (USD Million)
  • Fig. 25 In-vitro Colorectal Cancer Screening Tests Market Revenue, By Region
  • Fig. 26 Regional Marketplace: Key Takeaways
  • Fig. 27 Regional Marketplace: Key Takeaways
  • Fig. 28 North America In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Country Dynamics
  • Fig. 30 U.S. In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 31 Canada Country Dynamics
  • Fig. 32 Canada In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico Country Dynamics
  • Fig. 34 Mexico In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 36 U.K. Country Dynamics
  • Fig. 37 U.K. In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Country Dynamics
  • Fig. 39 Germany In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Country Dynamics
  • Fig. 41 Spain In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 42 France Country Dynamics
  • Fig. 43 France In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Country Dynamics
  • Fig. 45 Italy In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark Country Dynamics
  • Fig. 47 Denmark In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden Country Dynamics
  • Fig. 49 Sweden In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 50 Norway Country Dynamics
  • Fig. 51 Norway In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Country Dynamics
  • Fig. 54 Japan In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 55 China Country Dynamics
  • Fig. 56 China In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 57 India Country Dynamics
  • Fig. 58 India In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea Country Dynamics
  • Fig. 60 South Korea In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 61 Australia Country Dynamics
  • Fig. 62 Australia In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand Country Dynamics
  • Fig. 64 Thailand In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil Country Dynamics
  • Fig. 67 Brazil In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina Country Dynamics
  • Fig. 69 Argentina In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 70 Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa Country Dynamics
  • Fig. 72 South Africa In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia Country Dynamics
  • Fig. 74 Saudi Arabia In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 75 UAE Country Dynamics
  • Fig. 76 UAE In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 77 Kuwait Key Country Dynamics
  • Fig. 78 Kuwait In-vitro Colorectal Cancer Screening Tests Market, 2018 - 2030 (USD Million)
  • Fig. 79 Company Categorization
  • Fig. 80 Company Market Position Analysis
  • Fig. 81 Strategic Framework
目次
Product Code: 978-1-68038-438-3

In-vitro Colorectal Cancer Screening Tests Market Growth & Trends:

The global in-vitro colorectal cancer screening tests market size is expected to reach USD 1.7 billion by 2030, registering a CAGR of 4.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising number of novel screening models to combat the increasing incidences of colon and rectal malignancy cases is the major factor influencing the market growth. The emergence of newly developed genetic and biomarker tests such as tumor M2-PK stool tests and methylated gene testing is anticipated to drive the adoption rate of tumor diagnostic models.

The increasing incidence of colorectal malignancy is a significant driver for the growth of the segment. For example, according to data released by the National Cancer Center Japan in June 2022, it was projected that there would be approximately 1,019,000 new cases of cancer in Japan in 2022, with Colorectal Cancer (CRC) accounting for an estimated 158,200 new cases. Similarly, data updated by Cancer Australia in August 2022 indicated that 15,713 new cases of CRC were expected to be diagnosed in Australia in 2022, with 8,300 cases among males and 7,413 cases among females. As a result, the increasing prevalence of colorectal malignance is anticipated to drive the demand for colonoscopy devices.

The implementation of various initiatives by public organizations to promote screening has positively impacted the demand for in-vitro CRC screenings. For instance, according to reports from Cancer.org, healthcare systems in California continued to provide FIT kits (fecal immunochemical tests) during the months of April and May 2020, and the response rates for FIT remained high despite the onset of the COVID-19 pandemic. Additionally, the European Cancer community has mobilized its resources to evaluate, address, and mitigate the adverse effects of COVID-19 on screening. These efforts have contributed to the sustained demand for in-vitro screening tests.

Furthermore, market growth is expected to be driven by the increasing number of product launches by major market players. These product launches are aimed at providing access to technologically advanced and innovative products. For instance, Pillar Biosciences, Inc. received FDA approval for the ONCO/Reveal Dx Lung & Colon Cancer Assay (O/RDx-LCCA) in July 2021 for the detection of CRC.

In-vitro Colorectal Cancer Screening Tests Market Report Highlights:

  • The fecal occult blood tests segment dominated the in-vitro colorectal cancer screening tests industry, with the largest revenue share of 82.3% in 2024. The biomarker tests segment is anticipated to emerge as the fastest-growing segment and grow at a CAGR of 5.8% from 2025 to 2030.
  • The diagnostic laboratories segment held the largest revenue share in 2024, attributed to their advanced technology, high accuracy, and comprehensive testing capabilities. The hospitals and clinics segment is expected to grow at a significant pace during the forecast period, fueled by the increasing demand for early diagnosis and noninvasive testing options.
  • North America in-vitro colorectal cancer screening tests market dominated the global market with the largest revenue share of 39.5% in 2024. The U.S. in-vitro colorectal cancer screening tests market held the largest share in 2024.
  • Asia Pacific in-vitro colorectal cancer screening tests market is set to expand at the fastest CAGR of 5.2% from 2025 to 2030.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Test
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. In-vitro Colorectal Cancer Screening Tests Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. In-vitro Colorectal Cancer Screening Tests Market: Test Business Analysis

  • 4.1. Test Market Share, 2024 & 2030
  • 4.2. Test Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, By Test, 2018 to 2030 (USD Million)
  • 4.4. Fecal Occult Blood Tests
    • 4.4.1. Fecal Occult Blood Tests Market, 2018 - 2030 (USD Million)
    • 4.4.2. Guaiac FOB Stool Test
      • 4.4.2.1. Guaiac FOB Stool Test Market, 2018 - 2030 (USD Million)
    • 4.4.3. Immuno-FOB Agglutination Test
      • 4.4.3.1. Immuno-FOB Agglutination Test Market, 2018 - 2030 (USD Million)
    • 4.4.4. Lateral Flow Immuno-FOB Test
      • 4.4.4.1. Lateral Flow Immuno-FOB Test Market, 2018 - 2030 (USD Million)
    • 4.4.5. Immuno-FOB ELISA Test
      • 4.4.5.1. Immuno-FOB ELISA Test Market, 2018 - 2030 (USD Million)
  • 4.5. Biomarker Tests
    • 4.5.1. Biomarker Tests Market, 2018 - 2030 (USD Million)
  • 4.6. Other Methods
    • 4.6.1. Other Methods Market, 2018 - 2030 (USD Million)

Chapter 5. In-vitro Colorectal Cancer Screening Tests Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals and Clinics
    • 5.4.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)
  • 5.5. Diagnostic Laboratories
    • 5.5.1. Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. In-vitro Colorectal Cancer Screening Tests Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamic
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamic
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamic
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. U.K.
      • 6.5.2.1. Key Country Dynamic
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. U.K. In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamic
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Spain
      • 6.5.4.1. Key Country Dynamic
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. Spain In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. France
      • 6.5.5.1. Key Country Dynamic
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. France In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Italy
      • 6.5.6.1. Key Country Dynamic
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Italy In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamic
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Denmark In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamic
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Sweden In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamic
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Norway In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamic
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamic
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamic
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamic
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamic
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamic
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamic
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamic
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamic
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamic
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamic
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamic
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait In-vitro Colorectal Cancer Screening Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Abbott
      • 7.5.1.1. Participant's Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Epigenomics AG
      • 7.5.2.1. Participant's Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Beckman Coulter, Inc.
      • 7.5.3.1. Participant's Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Eiken Chemical Co., Ltd.
      • 7.5.4.1. Participant's overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Sysmex Corporation
      • 7.5.5.1. Participant's Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Siemens Healthineers AG
      • 7.5.6.1. Participant's Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Quest Diagnostics Incorporated
      • 7.5.7.1. Participant's Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Oncocyte Corporation
      • 7.5.8.1. Participant's Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Merck KGaA
      • 7.5.9.1. Participant's Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Immunostics Inc.
      • 7.5.10.1. Participant's Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives
    • 7.5.11. Kyowa Kirin Co., Ltd.
      • 7.5.11.1. Participant's Overview
      • 7.5.11.2. Financial Performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic Initiatives
    • 7.5.12. Randox Laboratories Ltd.
      • 7.5.12.1. Participant's Overview
      • 7.5.12.2. Financial Performance
      • 7.5.12.3. Product Benchmarking
      • 7.5.12.4. Strategic Initiatives
    • 7.5.13. R-Biopharm AG
      • 7.5.13.1. Participant's Overview
      • 7.5.13.2. Financial Performance
      • 7.5.13.3. Product Benchmarking
      • 7.5.13.4. Strategic Initiatives